Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study

Abstract Aim The wearable cardioverter‐defibrillator (WCD) is used for temporary protection from sudden cardiac death (SCD) in patients with newly diagnosed heart failure with reduced ejection fraction before considering an implantable cardioverter‐defibrillator (ICD). However, the prognostic signif...

Full description

Bibliographic Details
Main Authors: Johanna Mueller‐Leisse, Johanna Brunn, Christos Zormpas, Stephan Hohmann, Henrike Aenne Katrin Hillmann, Jörg Eiringhaus, Johann Bauersachs, Christian Veltmann, David Duncker
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13586